CAS 151213-15-9

1-Cyclopropyl-6,8-difluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid

Description:

1-Cyclopropyl-6,8-difluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid, with CAS number 151213-15-9, is a synthetic organic compound characterized by its complex bicyclic structure, which includes a quinoline core and a pyrrolopyridine moiety. This compound features multiple functional groups, including a carboxylic acid and fluorine substituents, which can influence its chemical reactivity and biological activity. The presence of the cyclopropyl group may contribute to its unique steric and electronic properties. Its structural complexity suggests potential applications in medicinal chemistry, particularly in the development of pharmaceuticals targeting specific biological pathways. The difluorination may enhance lipophilicity and metabolic stability, while the overall molecular architecture could be designed to interact with specific receptors or enzymes. As with many compounds of this nature, understanding its solubility, stability, and interaction with biological systems would be crucial for assessing its potential therapeutic uses.

Formula: C₂₀H₂₁F₂N₃O₃

InChI: InChI=1/C20H21F2N3O3/c21-14-6-12-17(25(11-3-4-11)8-13(19(12)26)20(27)28)16(22)18(14)24-7-10-2-1-5-23-15(10)9-24/h6,8,10-11,15,23H,1-5,7,9H2,(H,27,28)/t10-,15+/m0/s1

InChI key: InChIKey=WEXQOLCYKFJAJZ-ZUZCIYMTSA-N

SMILES: FC1=C2N(C=C(C(O)=O)C(=O)C2=CC(F)=C1N3C[C@]4([C@@](C3)(NCCC4)[H])[H])C5CC5

Synonyms:

• 1-Cyclopropyl-6,8-difluoro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
• 1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid
• 3-quinolinecarboxylic acid, 1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-
• 6H-Pyrrolo[3,4-b]pyridine, 3-quinolinecarboxylic acid deriv.
• 3-Quinolinecarboxylic acid, 1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-(octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-, (4aS-cis)-
• Moxifloxacin Imp. A RS IP
• Moxifloxacin hydrochloride impurity A
• Moxifloxacin Related CoMpound A
• Moxifloxacin impurity 1/Moxifloxacin EP Impurity A/Moxifloxacin Difluoro Analog/8-Desmethoxy-8-Fluoro Moxifloxacin/1-cyclopropyl-6,8-difluoro-7-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
• Moxifloxacin Related Matter 1
• Moxifloxacin impurity A
• 1-cyclopropyl-6-fluoro-7-amino-8-methoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid, 1-cyclopropyl-7-amino-6-fluoro-8-methoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid, 7-amino-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-4-oxoquinoline-3-carboxylic acid
• 3-Quinolinecarboxylic acid, 1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-(octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-, (4aS-cis)- USP/EP/BP
• Moxifloxacin EP Impurity A : Moxifloxacin Impurity A
• 1-cyclopropyl-6,8-difluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride
• Moxifloxacin EP IMpurity A
• Moxifloxacin Related Compound A (25 mg) (1-cyclopropyl-6,8-difluoro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid)
• 8-Desmethoxy-8-fluoro Moxifloxacin
• 1-Cyclopropyl-6,8-difluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo-[3,4-b]pyridin-6(2H)-yl)-4-oxo-1
• Moxifloxacin Hydrochloride IMpurity-A(EP)(USPRC A)
• Moxifloxacin IMp. A (EP,BP)
• 8-Ddesmethoxy-8-fluoroMoxifloxacin
• 1-Cyclopropyl-6,8-difluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
• Moxifloxacin EP Impurity A HCl USP/EP/BP
• Moxifloxacin EP Impurity A/ Moxifloxacin Related Compound A (Moxifloxacin Difluoro Analog)
• 1-Cyclopropyl-6,8-difluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo-[3,4-b]pyridin-6(2H)-yl)-4-oxo-1,4-d
• Moxifloxacin Related Compound A (25 mg) (1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid)
• Moxifloxacin related substance A
• USP Moxifloxacin Related Compound A
• Moxifloxacin impurity 2/Moxifloxacin EP Impurity A HCl/Moxifloxacin Difluoro Analog HCl/8-Desmethoxy-8-fluoro Moxifloxacin HCl/1-cyclopropyl-6,8-difluoro-7-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid Hydrochloride
• Moxifloxacin Related Matter A
• Mosisasin ImpurityA

Moxifloxacin Related Compound A (1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid)

CAS: 151213-15-9

Compounds containing a quinoline or isoquinoline ring-system, whether or not hydrogenated, not further fused, excluding drugs and pesticides

Formula: C₂₀H₂₁F₂N₃O₃

Color and Shape: White Off-White Powder

Molecular weight: 389.1551

Ref: 45-1448617

3-Quinolinecarboxylic acid, 1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-

CAS: 151213-15-9

Formula: C₂₀H₂₁F₂N₃O₃

Purity: 95%

Color and Shape: Solid

Molecular weight: 389.3958

Ref: IN-DA001N5P

Moxifloxacin EP Impurity A HCl (Moxifloxacin USP Related Compound A HCl)

CAS: 151213-15-9

Formula: C₂₀H₂₁F₂N₃O₃·HCl

Color and Shape: Pale Yellow Solid

Molecular weight: 389.40 36.46

Ref: 4Z-M-2714

1-Cyclopropyl-6,8-difluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

CAS: 151213-15-9

1-Cyclopropyl-6,8-difluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

Purity: 95%

Molecular weight: 389.4g/mol

Ref: 54-PC1007442

1-Cyclopropyl-6,8-difluoro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid

CAS: 151213-15-9

Color and Shape: Neat

Ref: 86-MM0885.04

Moxifloxacin EP Impurity A

CAS: 151213-15-9

Formula: C₂₀H₂₁F₂N₃O₃

Molecular weight: 389.40

Ref: ST-EA-CP-M26001

8-Desmethoxy-8-fluoro Moxifloxacin

CAS: 151213-15-9

Impurity Moxifloaxacin EP Impurity A
Stability Hygroscopic
Applications 8-Desmethoxy-8-fluoro Moxifloxacin (Moxifloaxacin EP Impurity A) is an impurity of Moxifloxacin (M745000).
References Martel, A., et al.: Drugs Fut., 22, 109 (1997), Tobin, C., et al.: J. Antimicrob. Chemother., 42, 278 (1998),

Formula: C₂₀H₂₁F₂N₃O₃

Color and Shape: Neat

Molecular weight: 389.40

Ref: TR-D445850

1-Cyclopropyl-6,8-difluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

CAS: 151213-15-9

Formula: C₂₀H₂₁F₂N₃O₃

Purity: 95%

Molecular weight: 389.403

Ref: 10-F230378

8-Desmethoxy-8-fluoro moxifloxacin

CAS: 151213-15-9

8-Desmethoxy-8-fluoro moxifloxacin is a photolytic drug that is used to treat bacterial infections. It has a high degree of antibacterial activity against methicillin-resistant staphylococcus aureus, including methicillin resistant strains of Staphylococcus epidermidis. 8-Desmethoxy-8-fluoro moxifloxacin hydrochloride is produced by the addition of hydrochloric acid to moxifloxacin, which is then purified by ion chromatography. The compound has been shown to have good stability in human plasma and urine. It also shows excellent recoveries in acetonitrile and quantification results in flow rates.

Formula: C₂₀H₂₁F₂N₃O₃

Purity: Min. 95%

Molecular weight: 389.4 g/mol

Ref: 3D-FD21225